Solid Biosciences: FDA Lifts Clinical Hold On IGNITE DMD Clinical Trial

Solid Biosciences Inc. (SLDB), said Thursday that the U.S. Food and Drug Administration or FDA has lifted the clinical hold placed on the company's IGNITE DMD Phase I/II clinical trial.

from RTT - Biotech https://ift.tt/36p25j0
via IFTTT